LINC-ROR and diabetes mellitus: We previously published that ROR can be targeted by synthetic ligands and protects against inflammation, diabetes, and cardiovascular diseases (4, 5, 18), but unfortunately, we have not been able to decipher the specific role of each receptor isotype nor the role of various isotypes within specific tissues with great precision.